[{"address1": "The Stiller Centre", "address2": "Suite 114 700 Collip Circle", "city": "London", "state": "ON", "zip": "N6G 4X8", "country": "Canada", "phone": "519 858 5126", "fax": "519 858 5099", "website": "https://www.sernova.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Cynthia  Pussinen", "title": "CEO & Director", "fiscalYear": 2023, "totalPay": 402675, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Modestus  Obochi M.B.A., Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "totalPay": 220540, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Shannon M.D.", "title": "Vice President of Clinical Development & Regulatory Affairs", "fiscalYear": 2023, "totalPay": 254908, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas J. Rossettos CPA, M.B.A.", "age": 57, "title": "Interim Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Maret", "title": "Chief Science Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Barnes", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "totalPay": 119536, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.2175, "open": 0.2175, "dayLow": 0.2175, "dayHigh": 0.2175, "regularMarketPreviousClose": 0.2175, "regularMarketOpen": 0.2175, "regularMarketDayLow": 0.2175, "regularMarketDayHigh": 0.2175, "beta": 1.523, "volume": 2500, "regularMarketVolume": 2500, "averageVolume": 21770, "averageVolume10days": 16850, "averageDailyVolume10Day": 16850, "bid": 0.226, "ask": 0.238, "marketCap": 68175368, "fiftyTwoWeekLow": 0.2, "fiftyTwoWeekHigh": 0.77, "fiftyDayAverage": 0.2452, "twoHundredDayAverage": 0.4155, "currency": "USD", "enterpriseValue": 58930784, "floatShares": 265105489, "sharesOutstanding": 303612992, "heldPercentInsiders": 0.12698, "heldPercentInstitutions": 0.00049, "bookValue": -0.018, "lastFiscalYearEnd": 1698710400, "nextFiscalYearEnd": 1730332800, "mostRecentQuarter": 1714435200, "netIncomeToCommon": -41321944, "trailingEps": -0.1, "enterpriseToEbitda": -1.414, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "SEOVF", "underlyingSymbol": "SEOVF", "shortName": "SERNOVA CORPORATION", "longName": "Sernova Corp.", "firstTradeDateEpochUtc": 1172068200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3d703eda-d9c8-3ac5-9889-441c90c9f6ed", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2175, "recommendationKey": "none", "totalCash": 8477794, "totalCashPerShare": 0.028, "ebitda": -41677172, "totalDebt": 613786, "quickRatio": 0.579, "currentRatio": 0.619, "returnOnAssets": -1.05195, "returnOnEquity": -3.10418, "freeCashflow": -11895146, "operatingCashflow": -27313620, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-07-16"}]